507 related articles for article (PubMed ID: 19034875)
21. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction?
Gianturco V; Bellomo A; D'Ottavio E; Formosa V; Iori A; Mancinella M; Troisi G; Marigliano V
Arch Gerontol Geriatr; 2009; 49 Suppl 1():129-33. PubMed ID: 19836626
[TBL] [Abstract][Full Text] [Related]
22. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
[TBL] [Abstract][Full Text] [Related]
23. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
24. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
[TBL] [Abstract][Full Text] [Related]
25. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.
Himmelfarb J; Phinney S; Ikizler TA; Kane J; McMonagle E; Miller G
J Ren Nutr; 2007 Sep; 17(5):296-304. PubMed ID: 17720098
[TBL] [Abstract][Full Text] [Related]
26. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.
Tekin IO; Pocan B; Borazan A; Ucar E; Kuvandik G; Ilikhan S; Demircan N; Ozer C; Kadayifci S
Ren Fail; 2008; 30(2):219-25. PubMed ID: 18300125
[TBL] [Abstract][Full Text] [Related]
27. Reduction of myocardial ischemia with simvastatin in addition to conventional treatment in patients with chronic coronary artery disease.
Verri V; Cunha AB; Tessarolo LE; Carneiro RC; Romêo Filho LJ
Rev Port Cardiol; 2004 Sep; 23(9):1089-105. PubMed ID: 15587571
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
Patrick L; Uzick M
Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
[TBL] [Abstract][Full Text] [Related]
29. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.
Fried L; Solomon C; Shlipak M; Seliger S; Stehman-Breen C; Bleyer AJ; Chaves P; Furberg C; Kuller L; Newman A
J Am Soc Nephrol; 2004 Dec; 15(12):3184-91. PubMed ID: 15579522
[TBL] [Abstract][Full Text] [Related]
31. Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients: effect of statins.
Farah R; Shurtz-Swirski R; Dorlechter F
Minerva Cardioangiol; 2010 Apr; 58(2):175-81. PubMed ID: 20440247
[TBL] [Abstract][Full Text] [Related]
32. Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease.
Namli S; Oflaz H; Turgut F; Alisir S; Tufan F; Ucar A; Mercanoglu F; Ecder T
Ren Fail; 2007; 29(1):55-9. PubMed ID: 17365910
[TBL] [Abstract][Full Text] [Related]
33. Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Nikolov IG; Joki N; Mothu N; Maizel J; Westenfeld R; Ketteler M; Lacour B; Drüeke TB; Massy ZA
J Urol; 2008 Apr; 179(4):1631-6. PubMed ID: 18295249
[TBL] [Abstract][Full Text] [Related]
34. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on low-density lipoprotein cholesterol, interleukin-6, and high-sensitivity C-reactive protein in end-stage renal disease.
Soliemani A; Nikoueinejad H; Tabatabaizade M; Mianehsaz E; Tamadon M
Iran J Kidney Dis; 2011 Jan; 5(1):29-33. PubMed ID: 21189431
[TBL] [Abstract][Full Text] [Related]
35. Inflammatory markers and the progression of IgA glomerulonephritis.
Kaartinen K; Syrjänen J; Pörsti I; Hurme M; Harmoinen A; Pasternack A; Huhtala H; Mustonen J
Nephrol Dial Transplant; 2008 Apr; 23(4):1285-90. PubMed ID: 17986475
[TBL] [Abstract][Full Text] [Related]
36. Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients.
Yamada K; Fujimoto S; Tokura T; Fukudome K; Ochiai H; Komatsu H; Sato Y; Hara S; Eto T
Ren Fail; 2005; 27(4):361-5. PubMed ID: 16060120
[TBL] [Abstract][Full Text] [Related]
37. Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
Rajagopalan S; Zannad F; Radauceanu A; Glazer R; Jia Y; Prescott MF; Kariisa M; Pitt B
Am J Cardiol; 2007 Jul; 100(2):222-6. PubMed ID: 17631074
[TBL] [Abstract][Full Text] [Related]
38. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
Nanayakkara PW; Kiefte-de Jong JC; Stehouwer CD; van Ittersum FJ; Olthof MR; Kok RM; Blom HJ; van Guldener C; ter Wee PM; Smulders YM
Nephrol Dial Transplant; 2008 Aug; 23(8):2586-92. PubMed ID: 18287179
[TBL] [Abstract][Full Text] [Related]
39. Effects of plant sterol and stanol ester consumption on lipid metabolism, antioxidant status and markers of oxidative stress, endothelial function and low-grade inflammation in patients on current statin treatment.
De Jong A; Plat J; Bast A; Godschalk RW; Basu S; Mensink RP
Eur J Clin Nutr; 2008 Feb; 62(2):263-73. PubMed ID: 17487211
[TBL] [Abstract][Full Text] [Related]
40. Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.
Bowden RG; Wilson RL; Deike E; Gentile M
Nutr Clin Pract; 2009; 24(4):508-12. PubMed ID: 19461006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
